Wealthfront Advisers LLC Edwards Lifesciences Corp Transaction History

Wealthfront Advisers LLC

$32.2 Billion
Q3 2024

A detailed history of Wealthfront Advisers LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Wealthfront Advisers LLC holds 16,102 shares of EW stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,102

Previous 35,461 54.59%

Holding current value

$1.19 Million

Previous $3.28 Million 67.57%

% of portfolio

0.0%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$59.7 - $93.78 $1.16 Million - $1.82 Million	-19,359 Reduced 54.59%	16,102 $1.06 Million
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $84 - $94	1 Added 0.0%	35,461 $3.28 Million
Q1 2024 Apr 19, 2024	BUY	$72.54 - $95.56 $23,285 - $30,674	321 Added 0.91%	35,460 $3.39 Million
Q4 2023 Feb 09, 2024	SELL	$61.71 - $77.76 $1.26 Million - $1.58 Million	-20,353 Reduced 36.68%	35,139 $2.68 Million
Q3 2023 Nov 01, 2023	BUY	$69.28 - $93.38 $1.26 Million - $1.69 Million	18,145 Added 48.58%	55,492 $3.84 Million
Q2 2023 Aug 07, 2023	BUY	$81.41 - $94.33 $128,627 - $149,041	1,580 Added 4.42%	37,347 $3.52 Million
Q1 2023 Apr 28, 2023	BUY	$74.26 - $84.51 $228,349 - $259,868	3,075 Added 9.41%	35,767 $2.96 Million
Q4 2022 Feb 10, 2023	SELL	$68.3 - $87.44 $290,479 - $371,882	-4,253 Reduced 11.51%	32,692 $2.44 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $122,072 - $159,003	1,482 Added 4.18%	36,945 $3.05 Million
Q2 2022 Jul 20, 2022	SELL	$86.5 - $128.27 $106,568 - $158,028	-1,232 Reduced 3.36%	35,463 $3.37 Million
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $653,869 - $823,044	6,413 Added 21.18%	36,695 $4.32 Million
Q4 2021 Jan 21, 2022	BUY	$106.37 - $130.68 $425,905 - $523,242	4,004 Added 15.24%	30,282 $3.92 Million
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $407,111 - $485,599	3,956 Added 17.72%	26,278 $2.98 Million
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $205,575 - $256,871	2,452 Added 12.34%	22,322 $2.31 Million
Q1 2021 May 14, 2021	BUY	$78.68 - $90.67 $11,644 - $13,419	148 Added 0.75%	19,870 $1.66 Million
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $34,554 - $43,972	-482 Reduced 2.39%	19,722 $1.8 Million
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $24,255 - $31,565	-361 Reduced 1.76%	20,204 $1.61 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $779,724 - $1.04 Million	13,551 Added 193.2%	20,565 $1.42 Million
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $132,335 - $204,525	-2,525 Reduced 26.47%	7,014 $1.32 Million
Q4 2019 Jan 21, 2020	BUY	$71.7 - $82.09 $31,404 - $35,955	438 Added 4.81%	9,539 $2.23 Million
Q3 2019 Oct 15, 2019	BUY	$61.55 - $75.43 $31,144 - $38,167	506 Added 5.89%	9,101 $2 Million
Q2 2019 Aug 13, 2019	SELL	$55.74 - $64.41 $12,708 - $14,685	-228 Reduced 2.58%	8,595 $1.59 Million
Q1 2019 May 13, 2019	BUY	$47.89 - $64.05 $107,656 - $143,984	2,248 Added 34.19%	8,823 $1.69 Million
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $305,145 - $374,380	6,575 New	6,575 $1.01 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthfront Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthfront Advisers LLC with notifications on news.

Account

Wealthfront Advisers LLC Edwards Lifesciences Corp Transaction History